HALO vs HRMY Stock Comparison

HALO currently leads HRMY in this stock comparison, with AIQ scores of 78 vs 73. The clearest difference is momentum, while HRMY has the stronger value profile.

Market data as of Nov 15, 2026 market close· AIQ score gap 5 points
HALO
Healthcare
vs
HRMY
Healthcare
HALO
Halozyme Therapeutics, Inc.
Leads
Price
$100
Day move
-0.4%
AIQ Score
78/100
Best edge
Momentum
Sector
Healthcare
HRMY
Harmony Biosciences Holdings, Inc.
Price
$33.76
Day move
-0.12%
AIQ Score
73/100
Best edge
Value
Sector
Healthcare

What is the main difference between HALO and HRMY?

HALO leads the current stock comparison as Halozyme Therapeutics, Inc., with the clearest separation coming from momentum and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Halozyme Therapeutics, Inc. vs Harmony Biosciences Holdings, Inc.

Data as of Nov 15, 2026· market close· Healthcare· Coverage 64/66 fields· High confidence
AIQ VerdictFragileAIQ Comparison Conviction 3/10

HALO leads

HALO leads by 5 AIQ points, primarily on Momentum and Quality, and the lead has widened from 1 points over 30 sessions. Wall Street currently favors HRMY on target upside.

Fragile: 3 of 6 evidence groups support HALO, its lead is widening, and its current signal state is conflicted.

Evidence agreement: 3 of 6Comparison trend: Strengthening
HALO

Halozyme Therapeutics, Inc.

Leads
AIQ Score
78/100
AIQ Edge Score
10/10
HRMY

Harmony Biosciences Holdings, Inc.

AIQ Score
73/100
AIQ Edge Score
9/10

The Algovestiq AIQ Score currently favors HALO over HRMY, 78 versus 73 as of Nov 15, 2026. HALO's advantage is driven primarily by stronger momentum and quality, while HRMY holds the stronger value profile. HALO also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors HRMY. 3 of 6 covered evidence groups favor HALO today, and the comparison is rated Fragile on stability: the AIQ gap is narrow at 5 points. HALO lead: Strengthening — the AIQ differential moved from 1 to 5 points over 30 sessions.

Compare Halozyme Therapeutics, Inc. and Harmony Biosciences Holdings, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Price return from daily closes; distributions are not included.

HALO
+172.3%
HRMY
-15.9%

Price return comparison

Growth of $10,000, price only

HALO $27,232 · HRMY $8,413

Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.

Compare HALO and HRMY against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

HALO advantage
0
HRMY advantage
  • Momentum84 vs 66
    HALO +18
  • Value76 vs 89
    HRMY +13
  • Quality81 vs 77
    HALO +4
  • Risk Resilience63 vs 63
    Even

3 of 6 evidence groups favor HALO. HALO’s edge is concentrated in momentum and quality; HRMY keeps a meaningful value edge.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

HALO-2 AIQ

Largest factor move: Momentum -4

No signal started or stopped since the prior session; its 5 active signals are unchanged.

HRMY0 AIQ

Largest factor move: Quality +1, not enough on its own to move the overall score.

No signal started or stopped since the prior session; its 3 active signals are unchanged.

HALO's lead narrowed by 2 AIQ points in the latest session.

Deeper signal detail for each name lives on its own signals page — HALO and HRMY both carry a full feed there.

The central trade-off

HALO (Halozyme Therapeutics, Inc.): the stronger current systematic profile, led by momentum and quality.

HRMY (Harmony Biosciences Holdings, Inc.): the counter-case, on value, valuation, analyst expectations.

The AIQ Score and Wall Street therefore point in different directions on this pair.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

HALO

HALO on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

HALO

HALO on combined revenue and EPS growth.

Value

HRMY

HRMY on the peer-relative Value factor, by 13 points.

Momentum

HALO

HALO on the Momentum factor, by 18 points.

Lower downside

HRMY

HRMY carries the lower 1-month annualized volatility.

Analyst upside

HRMY

HRMY on implied upside to the consensus price target.

AIQ vs Wall Street

The model and the Street disagree here: AIQ favors HALO, analyst targets favor HRMY. That disagreement is the most useful thing on this page.

MeasureHALOHRMYNote
Implied upside to target+22.7%+52.5%HRMY has more room
Target dispersion+17.1%+35%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering1112Higher coverage generally improves confidence

The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

3 of 6 covered evidence groups favor HALO. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreHALO78 vs 73
FundamentalsHALOon balancerevenue growth 2.5% vs 2.9%; EPS growth 10.7% vs -36.2%; TTM ROE -4.5% vs 4.5%; gross margin 82.3% vs 74%; operating margin 55.9% vs 22.2% — HALO takes 3 of 4 decided legs, not all of them
ValuationHRMYValue 76 vs 89
TechnicalsHALOPrice vs 50-day -12.5% vs -12.6%; vs 200-day 17.4% vs -2.4%
Risk ResilienceEvenRisk Resilience 63 vs 63
Analyst expectationsHRMYTarget upside 22.7% vs 52.5%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of HALO and HRMY and are excluded from the count.

AIQ Decision Stability

Fragile

The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.

  • The AIQ gap is narrow at 5 points. (argues the conclusion is provisional)
  • Only 3 of 6 covered evidence groups agree. (argues the conclusion is provisional)
  • The leader's advantage has been widening. (supports the conclusion holding)
  • The lead has been steady session to session. (supports the conclusion holding)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on HALO.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

HALO lead: Strengthening — the AIQ differential moved from 1 to 5 points over 30 sessions.

May 27HALO leads above the line · HRMY leads belowNov 13
Today
HALO +5
78 vs 73
7 sessions ago
HALO +4
80 vs 76
30 sessions ago
HALO +1
81 vs 80
90 sessions ago
HALO +3
77 vs 74

The lead changed hands once in this window, most recently on Jun 5 when HALO moved ahead of HRMY.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

HALOConflicted

2 bullish / 1 bearish / 2 neutral, conflicted

Only HALO

  • Keltner Channel Breakdown — bearish, volatility, short horizon
  • RSI Oversold — bullish, momentum, short horizon
HRMY

1 bullish / 0 bearish / 2 neutral

No signal that the other name lacks.

Both carry 3 more signals that do not separate them: Golden Cross Active, ADX Trend Strengthening, ATR Expansion - Breakout Mode.

HALO leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

HALOConfirmed weakness

Price and the AIQ Score both moved down over the latest session (price -0.4%, AIQ -2 points).

HRMYNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -0.12%, AIQ 0 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1HRMY closes the Momentum gap — currently 18 points behind, the largest single contributor to HALO's edge.
  2. 2HRMY's ADX Trend Strengthening turns directional — it is neutral today and would confirm a change in trend.
  3. 3HALO's conflicting signal state resolves bearish — it currently carries 2 bullish and 1 bearish rules at once.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

HALO leads on balance
MetricHALOHRMY
Revenue growth (YoY)2.5%2.9%
EPS growth (YoY)10.7%-36.2%
Gross margin82.3%74%
Operating margin55.9%22.2%
Return on equity (TTM)-4.5%4.5%
Debt to equity-58.840.14

Performance

HALO leads 4 of 6 windows
MetricHALOHRMY
1 week (5 sessions)-3.2%2%
1 month (20 sessions)-17.7%-11%
3 months (63 sessions)-2.7%-11.5%
6 months (126 sessions)49.4%12.2%
Year to date49%-9.8%
1 year (252 sessions)42%0.7%

Technicals

HALO has the stronger structure
MetricHALOHRMY
RSI (14)26.736.4
ADX (14)40.234.7
Price vs 50-day-12.5%-12.6%
Price vs 200-day17.4%-2.4%
Volatility (1M, annualized)61%46.4%

Risk

Split
MetricHALOHRMY
Beta0.580.63
Sharpe ratio0.950.07
Sortino ratio1.470.09
Max drawdown-24.1%-34.5%
Current drawdown-23.6%-21.2%
Annualized volatility41%40.6%
Value at risk (95%)-2.8%-3.9%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, HALO or HRMY?

On the Algovestiq AIQ Score, HALO is the stronger of the two as of Nov 15, 2026, scoring 78 against HRMY's 73. The edge comes from momentum and quality. HRMY is not without a case — it holds the better value profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is HALO or HRMY the better buy right now?

HALO carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Fragile — 3 of 6 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the AIQ gap is narrow at 5 points. Treat the lead as provisional.

Why does the AIQ Score favor HALO over HRMY?

The composite weights Quality, Value, Momentum and Risk Resilience. HALO leads Momentum by 18 points; HRMY leads Value by 13 points; HALO leads Quality by 4 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, HALO or HRMY?

Analyst price targets imply +22.7% upside for HALO and +52.5% for HRMY, so the Street currently favors HRMY. That points the opposite way to the AIQ Score, which favors HALO. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, HALO or HRMY?

HRMY is the better-valued of the two on the peer-relative Value factor. HRMY on the peer-relative Value factor, by 13 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, HALO or HRMY?

HALO on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, HALO or HRMY?

HALO on the Momentum factor, by 18 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, HALO or HRMY?

HRMY is the more resilient of the two, so the other name carries the higher downside risk. HRMY carries the lower 1-month annualized volatility. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is HALO more profitable than HRMY?

The profitability evidence is mixed: gross margin 82.3% vs 74%; operating margin 55.9% vs 22.2%; ttm roe -4.5% vs 4.5%. HALO leads on two measures and HRMY on one measure, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.

Is HALO's lead over HRMY getting stronger or weaker?

HALO lead: Strengthening — the AIQ differential moved from 1 to 5 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands once in that window, most recently on 2026-06-05, when HALO moved ahead of HRMY.

What would change the HALO vs HRMY verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: HRMY closes the Momentum gap — currently 18 points behind, the largest single contributor to HALO's edge; HRMY's ADX Trend Strengthening turns directional — it is neutral today and would confirm a change in trend; HALO's conflicting signal state resolves bearish — it currently carries 2 bullish and 1 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about HALO and HRMY?

HALO: 2 bullish / 1 bearish / 2 neutral, conflicted. HRMY: 1 bullish / 0 bearish / 2 neutral. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on HALO is Golden Cross Active (bullish, long horizon). On HRMY it is Golden Cross Active (bullish, long horizon).

Compare HALO and HRMY with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.